Cherry, I certainly believe it could go $5 or more, but it will depend on what spurs the next leg up.
I believe we should also be thinking about where we'll be at the end of the next quarter. If at that time it's clear that our psoriasis cream will be on the market shortly, I see no reason why our market cap shouldn't be in the $1 to $3 billion range, i.e. somewhere between about $7 and $20.
For now, I expect we'll learn a lot more about the company with the filing of their Annual Report, and hopefully a webcast. That may be what spur's the leg up.
Gary
Market Data 
Markets 
AI
